Through the Drug Effectiveness Review Project, researchers analyzed 69 decisions on whether to update 41 comparative drug effectiveness reviews. The Kaplan-Meier product limit method was used to estimate mean time to update, which was approximately 25 months. Predictors of the decision to update comparative drug effectiveness reviews were introduction of new drugs and the number of new relevant trials. Psychiatric topics, compared to nonpsychiatric topics, are more rapidly developing. Because of this, decisions to update reviews related to psychiatric topics occurred more frequently.
Read the study about comparative drug effectiveness reviews.
Read other coverage about medication safety:
– Hospital’s New Medication Cards Aim to Improve Medication Safety
– Study Shows Dramatic Increase of Unintentional Therapeutic Errors Involving Insulin
– Using Color to Differentiate Drug Strength Can Improve Medication Safety
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.